Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Reliable Monitoring of Respiratory Function with Home Spirometry in People Living with Amyotrophic Lateral Sclerosis

Julián Peller, Marcos A Trevisan, Gaston Bujia, Felipe Aguirre, Diego E. Shalom, Alan Taitz, Stephanie Henze, Silviya Bastola, Jason Osik, Ryan A. Shewcraft, Peng Jiang, Joel Schwartz, Terry Heiman-Patterson, Michael E. Sherman, Matthew F. Wipperman, Oren Levy, Guofa Shou, Karl A. Sillay, Lyle W. Ostrow, Ernest Fraenkel, James D. Berry, Indu Navar Bingham, Esteban G. Roitberg
doi: https://doi.org/10.1101/2025.02.03.25321333
Julián Peller
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
MSCS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: julian{at}everythingals.org
Marcos A Trevisan
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
2Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Física - CONICET – Universidad de Buenos Aires, Instituto de Física Interdisciplinaria y Aplicada (INFINA). Buenos Aires, Argentina
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaston Bujia
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felipe Aguirre
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego E. Shalom
2Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Física - CONICET – Universidad de Buenos Aires, Instituto de Física Interdisciplinaria y Aplicada (INFINA). Buenos Aires, Argentina
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Taitz
3SRI International, Menlo Park, CA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Henze
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silviya Bastola
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Osik
4Bristol Myers Squibb, Cambridge, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan A. Shewcraft
4Bristol Myers Squibb, Cambridge, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Jiang
4Bristol Myers Squibb, Cambridge, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Schwartz
4Bristol Myers Squibb, Cambridge, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terry Heiman-Patterson
5Lewis Katz School of Medicine at Temple University, Department of Neurology, Philadelphia, PA, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Sherman
6Department of Medicine, MCG-Hearst Health, Drexel University College of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew F. Wipperman
7Regeneron Pharmaceuticals, Tarrytown, NY, USA
PhD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oren Levy
7Regeneron Pharmaceuticals, Tarrytown, NY, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guofa Shou
8Eli Lilly and Company, Boston, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl A. Sillay
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lyle W. Ostrow
5Lewis Katz School of Medicine at Temple University, Department of Neurology, Philadelphia, PA, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernest Fraenkel
9Massachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Berry
10Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Indu Navar Bingham
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
MSCS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esteban G. Roitberg
1Peter Cohen Foundation dba Everything ALS, Seattle, Washington and Los Altos, California, USA
11Escuela de Ciencia y Tecnología, Universidad Nacional de San Martín, Buenos Aires, Argentina
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Monitoring respiratory function is essential for assessing the progression of Amyotrophic Lateral Sclerosis (ALS) and planning interventions. Using spirometry data from the Radcliff Study —a fully remote, longitudinal, exploratory study with a cohort of 67 pALS—we demonstrate that flexible coaching, combined with a quality control analysis that excludes values of ‘0’ and timepoints with failed measurement trials, produces consistent remote spirometry results. Our findings indicate that home-measured Slow Vital Capacity (SVC) and Forced Vital Capacity (FVC) evolve similarly and progress linearly over the study period (7.7 ± 4.0 months). This remains true in both slow and fast progressor subpopulations. This observed linearity in respiratory trajectories supports the potential for early, accurate estimation of progression, reinforcing the feasibility of less frequent monitoring without compromising assessment precision, and reducing the burden on both pALS and the healthcare system. Furthermore, our results align with reported in-clinic pulmonary tests, validating remote monitoring as a means to promote more equitable and accessible clinical trial designs.

Competing Interest Statement

JP, MAT, GB, FA and DES are paid consultants to EverythingALS. AT was a paid consultant to EverythingALS. Work was done while working at EverythingALS. Currently he is an employee of SRI International. SH and SB are paid consultants to EverythingALS. JO, RAS, PJ, JS are current employees of and report equity ownership in Bristol Myers Squibb. THP is a Medical Advisory Board for Mitsubishi Tanabe Pharma America, Amylyx and Novartis. She also received Clinical Trial funding from Novartis, and Clinical Study funding from Amylyx and Mitsubishi Tanabe Pharma America. MES declares no competing interests. MFW and OL are current employees and shareholders of Regeneron Pharmaceuticals, Inc. GS is an employee of Eli Lilly & Co. and holds company stock. KAS declares no competing interests. LWO and EF declare no competing interests. JDB has research support from Rapa Therapeutics, MT Pharma of America, ProJenX, Novartis, MDA, ALS Finding a Cure, ALS Association, Association for Frontotemporal Demenia and NINDS. He has been a consultant to Alexion Pharmaceuticals, Amylyx Pharmaceuticals, Biogen, MTPA, Regeneron Pharmaceuticals, Roon, Sanofi and Trace Neuroscience. He is an unpaid scientific advisor to EverythingALS. INB is the founder of EverythingALS. EGR is a paid consultant to EverythingALS.

Clinical Protocols

https://www.everythingals.org/radcliffstudy

Funding Statement

This study was funded by EverythingALS - Peter Cohen Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Salus IRB gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵* First coauthors.

Data availability

All data needed to reproduce the figures in this work are available at the EverythingALS Reliable Monitoring RPFTALS Github repository.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 06, 2025.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reliable Monitoring of Respiratory Function with Home Spirometry in People Living with Amyotrophic Lateral Sclerosis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reliable Monitoring of Respiratory Function with Home Spirometry in People Living with Amyotrophic Lateral Sclerosis
Julián Peller, Marcos A Trevisan, Gaston Bujia, Felipe Aguirre, Diego E. Shalom, Alan Taitz, Stephanie Henze, Silviya Bastola, Jason Osik, Ryan A. Shewcraft, Peng Jiang, Joel Schwartz, Terry Heiman-Patterson, Michael E. Sherman, Matthew F. Wipperman, Oren Levy, Guofa Shou, Karl A. Sillay, Lyle W. Ostrow, Ernest Fraenkel, James D. Berry, Indu Navar Bingham, Esteban G. Roitberg
medRxiv 2025.02.03.25321333; doi: https://doi.org/10.1101/2025.02.03.25321333
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Reliable Monitoring of Respiratory Function with Home Spirometry in People Living with Amyotrophic Lateral Sclerosis
Julián Peller, Marcos A Trevisan, Gaston Bujia, Felipe Aguirre, Diego E. Shalom, Alan Taitz, Stephanie Henze, Silviya Bastola, Jason Osik, Ryan A. Shewcraft, Peng Jiang, Joel Schwartz, Terry Heiman-Patterson, Michael E. Sherman, Matthew F. Wipperman, Oren Levy, Guofa Shou, Karl A. Sillay, Lyle W. Ostrow, Ernest Fraenkel, James D. Berry, Indu Navar Bingham, Esteban G. Roitberg
medRxiv 2025.02.03.25321333; doi: https://doi.org/10.1101/2025.02.03.25321333

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)